A clinical overview of Tilarin

Allergy: European Journal of Allergy and Clinical Immunology, Supplement

Volumn 51, Issue 28, 1996, Pages 28-34

  Knottnerus, Ivo G ^a   Riley, Patricia A ^b  

^a International Medical Services   (United Kingdom)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CROMOGLYCATE DISODIUM; NEDOCROMIL SODIUM;

ADULT; ALLERGIC RHINITIS; CHILD; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HUMAN; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PHARMACOKINETICS; POLLEN; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, INTRANASAL; ADULT; ANTI-ALLERGIC AGENTS; CHILD; DOUBLE-BLIND METHOD; DRUG EVALUATION, PRECLINICAL; HUMANS; METABOLIC CLEARANCE RATE; MIDDLE AGED; NEDOCROMIL; RHINITIS, ALLERGIC, SEASONAL; SEVERITY OF ILLNESS INDEX;

EID: 0029865047     PISSN: 01081675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. SCHULLER DE, SELCOW JE, JOOS TH, HANNAWAY PJ, HIRSCH SR, SCHWARTZ HJ, FILLEY WV, FINK JN. A multicenter trial of nedocromil sodium 1% nasal solution compared with cromolyn sodium and placebo in ragweed seasonal allergic rhinitis. J Allergy Clin Immunol 1990; 86: 554-561.
2. DICKER ID. (On behalf of the Italian multicentre study group) Nedocromil sodium 1% nasal spray in the treatment of children with seasonal allergic rhinitis caused by pollen. Allergy 1995; 50 (Suppl. 26): 69.
3. LUND VJ (Chairman) International Rhinitis Management Working Group. International consensus report on the diagnosis and management of rhinitis. Allergy 1994; 49 (suppl. 19): 1-34.
4. LUND VJ. Seasonal allergic rhinitis - a review of current therapy. Allergy 1996; 51 (suppl. 28): 5-7.
5. DAVIES RJ. Clinical implications of the pharmacological profile of Tilarin. Allergy 1996; 51 (suppl. 28): 8-13.
6. DONNELLY A, BERNSTEIN DI, GOLDSTEIN S, GROSSMAN J, SCHWARTZ HJ, CASALE TB. Speed of onset of action of Tilarin. Allergy 1996; 51 (suppl. 28): 14-19.
7. BUKSTEIN DA, BIONDI RM, BLUMENTHAL MN, DOCKHORN RJ, FILLEY WV, FINK J, GOLDSTEIN S, GRAFT DF, HIRSCH SR, JOOS TH, MELAMED J, ROWE MS, TOWNLEY RG. Tilarin in combination with astemizole. Allergy 1996; 51 (suppl. 28): 20-27.
8. NEALE MG, BROWN K, FOULDS RA, LAL S, MORRIS DA, THOMAS D. The pharmacokinetics of nedocromil sodium, a new drug for the treatment of reversible obstructive airways disease, in human volunteers and patients with reversible obstructive airways disease. Br J Clin Pharmacol 1987; 24: 493-501.
9. CLARK B, CLARKE AJ, BAMFORD DG, GREENWOOD B. Nedocromil sodium preclinical safety evaluation studies: a preliminary report. Eur J Respir Dis 1986; 69 (suppl. 147): 248-251.
10. GONZALES JP, BROGDEN RN. Nedocromil sodium. A Preliminary review of its pharmacodynamic and pharmacokinetic proerties and therapeutic efficacy in the treatment of reversible obdtructive airways disease. Drugs 1987; 34: 560-577.
11. KÖNIG P. Clinical overview of nedocromil sodium. Allergy Proc 1995; 16: 73-76.
12. KJELLMAN N-IM, STEVENS MT. Clinical experience with Tilavist: an overview of efficacy and safety. Allergy 1995; 50 (suppl. 21): 14-22.
13. RUHNO J, DENBURG J, DOLOVICH J. Intranasal nedocromil sodium in the treatment of ragweed-allergic rhinitis. J Allergy Clin Immunol 1988; 81: 570-574.
14. SCHWARTZ HJ, ELLIS LD, SHER TH. The efficacy and safety of nedocromil sodium 1% nasal solution in the treatment of ragweed seasonal allergic rhinitis. Am J Rhinology 1991; 5: 241-247.
15. DRUCE HM, GOLDSTEIN S, MELAMED J, GROSSMAN J, MOSS BA, TOWNLEY RG. A multicenter placebo-controlled study of nedocromil sodium 1% nasal solution in ragweed seasonal allergic rhinitis. Ann Allergy 1990; 65: 212-216.
16. BELLIONI P, SALVINELLI F, PATALANO F, RUGGIERI F. A double-blind group comparative study of nedocromil sodium in the treatment of seasonal allergic rhinitis. Rhinology 1988; 26: 281-287.
17. SIPILÄ P, SORRI M, PUKANDER J. Double-blind comparison of nedocromil sodium (1% nasal spray) and placebo in rhinitis caused by birch pollen. Clin Otolaryngology 1987; 12: 365-370.
18. ALEXANDER M. Comparative therapeutic studies with Tilavist. Allergy 1995; 50 (suppl. 21): 23-29.
19. BARNES PJ, HOLGATE ST, LAITINEN LA, PAUWELS R. Asthma mechanisms, determinants of severity and treatment: the role of nedocromil sodium. Clin Exp Allergy 1995; 25: 771-787.
20. VERLEDEN GM, BELVISI MG, STRETTON CD, BARNES PJ. Nedocromil sodium modulates nonadrenergic, noncholinergic bronchoconstrictor nerves in guinea pig airways in vitro. Am Rev Respir Dis 1991; 143: 114-118.
21. BARANIUK JN. Neural control of human nasal secretion. Pulmonary Pharmacol 1991; 4: 20-31.
22. JAVDAN P, FIGINI M, EMANUELI C, GEPPETTI P. Nedocromil sodium reduces allergen-induced plasma extravasation in the guinea-pig nasal mucosa by inhibition of tachykinin release. Allergy 1995; 50: 825-829.
23. MOQBEL R, CROMWELL O, WALSH GM, WARDLAW AJ, KURLAK L, KAY AB. The effects of nedocromil sodium (Tilade) on activation of human eosinophils, neutrophils and histamine release from mast cells. Allergy 1988; 43: 268-276.
24. NACLERIO RM, PROUD D, TOGIAS AG, ADKINSON NF, MEYERS DA, KAGEY-SOBOTKA A, PLAUT M, NORMAN PS, LICHTENSTEIN LM. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 1985; 313: 65-70.
25. SHELTON D, EISER N. Histamine receptors in the human nose. Clin Otolaryngol 1994; 19: 45-49.
26. BRAUNSTEIN GL, TRINQUET G, HARPER AE. Compliance with nedocromil sodium and with a combination of nedocromil sodium and salbutamol in mild to moderate asthma. Eur Respir J 1995; 8 (suppl. 19): 483S.
27. WOLTHERS OD, PEDERSEN S. Short-term growth in children with allergic rhinitis treated with oral antihistamine, depot and intranasal glucocorticosteroids. Acta Paediatr 1993; 82: 635-640.